The group of Yushe YANG has designed and synthesized a siderophore-conjugated monocyclic ß-lactam YT-14 which was very potent, in a phase I clinical study, against multidrug-resistant P. aeruginosa, A. baumannii and K. pneumoniae.
CAS news release, May 2, 2017